EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Retrospective Analysis of the Epidemiology and Risk Factors for Recurrent Biliary-Source Bloodstream Infections in Oncologic Patients

Paola Maffezzoli iD, Ignacio Grafia, Mar Cusó Banús, Aina Gutiérrez-Santos, Alba Fernández, Ana Peris, Laia Llobera, Maria Dolores Quesada, Daniela Buccione, Silvia Corcione, Carolina Tudela, Carme Bracke iD und 12 weitere

Antibiotics · 27.03.2026 · 15 (4) · 342

DOI: 10.3390/antibiotics15040342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Antibiotics, online erschienen am 27.03.2026. Verfasst von Paola Maffezzoli und 23 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Sciences, Internal Medicine, University of Turin, 10124 Turin, Italy. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, European Union.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

We aimed to describe the clinical and microbiological characteristics of biliary-source bloodstream infections (bBSIs) in patients with malignancies and identify risk factors for recurrence.

Methods

All bBSI episodes in patients with active solid tumors during 2021–2025 were retrospectively reviewed. Independent risk factors for recurrent bBSI and mortality were identified. A previously published recurrence risk score was externally validated.

Results

Overall, 136 patients experienced 199 bBSI episodes. Pancreatic (36.7%) and biliary tract (33.2%) were the most common cancers, and 60.8% had metastatic disease. The main pathogens were Escherichia coli (43.2%), Klebsiella pneumoniae (24.1%), and Enterococcus faecium (19.1%), and multidrug-resistant organisms accounted for 19.1%. Inappropriate empirical antibiotic treatment (IEAT) occurred in 37.2% and was independently associated with increased 30-day mortality, together with metastatic disease and septic shock. Thirty-day mortality was 24.6%. Recurrent bBSI occurred in 35.7% and was independently associated with biliary tract cancer, previous multidrug-resistant isolation, and prior hospitalization for suspected biliary infection. The externally validated recurrence score showed excellent discrimination (AUC 0.815). Conclusions: bBSI in oncology patients is associated with high rates of MDR pathogens, IEAT, recurrence, and mortality. A simple clinical score may identify patients at high risk of recurrence and guide preventive strategies.

Schlagwörter

Stichwörter der Autor:innen

bacteremiabiliary-source bloodstream infectioncholangitisempirical treatmentmortality

Autor:innen und Institutionen

  • Department of Medical Sciences, Internal Medicine, University of Turin, 10124 Turin, Italy.
  • Department of Infectious Diseases, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
  • Department of Medicine, Universitat de Barcelona (UB), 08036 Barcelona, Spain.
  • Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
  • Department of Dermatology, Hospital Universitari Germans Trias i Pujol, 08916 Badalona, Spain.
  • Department of Oncology, Hospital Universitari Germans Trias i Pujol, ICO, 08916 Badalona, Spain.

ORCID-Profile: Paola Maffezzoli, Carme Bracke, Alex Soriano, Roger Paredes, Pere-Joan Cardona, Francesco Giuseppe De Rosa, Pedro Puerta-Alcalde

Förderung

  • Instituto de Salud Carlos III
  • European Union

Zitieren

APA

Maffezzoli, P., Grafia, I., Banús, M. C., Gutiérrez-Santos, A., Fernández, A., Peris, A., Llobera, L., Quesada, M. D., Buccione, D., Corcione, S., Tudela, C., Bracke, C., Esquerrà, A., Romero, A., Cerdà, G., Benítez, R., Mateu, A., Sales, A., Soriano, A., …, & Puerta-Alcalde, P. (2026). Retrospective Analysis of the Epidemiology and Risk Factors for Recurrent Biliary-Source Bloodstream Infections in Oncologic Patients. Antibiotics, 15(4), 342. https://doi.org/10.3390/antibiotics15040342

Vancouver

Maffezzoli P, Grafia I, Banús MC, Gutiérrez-Santos A, Fernández A, Peris A, et al. Retrospective Analysis of the Epidemiology and Risk Factors for Recurrent Biliary-Source Bloodstream Infections in Oncologic Patients. Antibiotics. 2026;15(4):342. doi:10.3390/antibiotics15040342

BibTeX
@article{Maffezzoli2026,
  author = {Maffezzoli, Paola and Grafia, Ignacio and Banús, Mar Cusó and Gutiérrez-Santos, Aina and Fernández, Alba and Peris, Ana and Llobera, Laia and Quesada, Maria Dolores and Buccione, Daniela and Corcione, Silvia and Tudela, Carolina and Bracke, Carme and Esquerrà, Anna and Romero, Alba and Cerdà, Gabriela and Benítez, Rosa and Mateu, Aina and Sales, Anna and Soriano, Alex and Paredes, Roger and Cardona, Pere-Joan and De Rosa, Francesco Giuseppe and Pedro-Botet, María Luisa and Puerta-Alcalde, Pedro},
  title = {Retrospective Analysis of the Epidemiology and Risk Factors for Recurrent Biliary-Source Bloodstream Infections in Oncologic Patients},
  journal = {Antibiotics},
  year = {2026},
  volume = {15},
  number = {4},
  pages = {342},
  doi = {10.3390/antibiotics15040342}
}
Kostenlos starten →